Product Name |
Recombinant Human B-Cell CLL/Lymphoma 7A (Bcl7A) Protein |
Product Overview |
This recombinant human B-Cell CLL/Lymphoma 7A (Bcl7A) protein includes amino acids 1-210aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
Q4VC05 |
Recommended Name |
B-cell CLL/lymphoma 7 protein family member A |
Gene Name |
BCL7A |
Synonyms |
B-cell CLL/lymphoma 7 protein family member A, BCL7 |
Species |
Human |
Predicted Molecular Mass |
42 kDa |
Expression System |
E.coli |
Expression Range |
1-210aa |
Tag |
N-6His |
Purity |
>85% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Research Area |
Cancer |
Protein Family |
BCL7 family |
Associated Diseases |
Chromosomal aberrations involving BCL7A may be a cause of B-cell non-Hodgkin lymphoma. Three-way translocation t(8;14;12)(q24.1;q32.3;q24.1) with MYC and with immunoglobulin gene regions. |